Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:MSA NYSE:SNN NYSE:STE OTCMKTS:WILYY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMSAMSA Safety Incorporporated$169.12+2.4%$170.76$151.10▼$208.92$6.37B0.97283,832 shs223,315 shsSNNSmith & Nephew SNATS$30.98+0.4%$32.01$28.23▼$38.79$13.17B0.571.40 million shs1.16 million shsSTESTERIS$215.51+0.5%$218.56$195.14▼$269.44$21.03B0.95808,298 shs856,282 shsWILYYDemant A/S$18.05$15.66$13.45▼$21.93$7.64B1.13191 shs18 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMSAMSA Safety Incorporporated+2.27%-2.07%-2.58%-14.43%+6.26%SNNSmith & Nephew SNATS+0.49%+3.82%-9.38%-13.18%+5.43%STESTERIS+0.50%+2.22%-4.75%-14.13%-13.92%WILYYDemant A/S0.00%0.00%+5.42%+27.74%-6.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMSAMSA Safety Incorporporated$169.12+2.4%$170.76$151.10▼$208.92$6.37B0.97283,832 shs223,315 shsSNNSmith & Nephew SNATS$30.98+0.4%$32.01$28.23▼$38.79$13.17B0.571.40 million shs1.16 million shsSTESTERIS$215.51+0.5%$218.56$195.14▼$269.44$21.03B0.95808,298 shs856,282 shsWILYYDemant A/S$18.05$15.66$13.45▼$21.93$7.64B1.13191 shs18 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMSAMSA Safety Incorporporated+2.27%-2.07%-2.58%-14.43%+6.26%SNNSmith & Nephew SNATS+0.49%+3.82%-9.38%-13.18%+5.43%STESTERIS+0.50%+2.22%-4.75%-14.13%-13.92%WILYYDemant A/S0.00%0.00%+5.42%+27.74%-6.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMSAMSA Safety Incorporporated 2.29Hold$200.0018.26% UpsideSNNSmith & Nephew SNATS 2.40Hold$30.93-0.16% DownsideSTESTERIS 2.50Moderate Buy$275.6727.91% UpsideWILYYDemant A/S 3.33BuyN/AN/ACurrent Analyst Ratings BreakdownLatest STE, SNN, WILYY, and MSA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026STESTERIS KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$291.00 ➝ $269.005/11/2026SNNSmith & Nephew SNATS Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$31.855/11/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$32.00 ➝ $30.005/11/2026MSAMSA Safety Incorporporated DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$235.00 ➝ $206.005/6/2026MSAMSA Safety Incorporporated Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$197.004/24/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.004/20/2026SNNSmith & Nephew SNATS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)4/16/2026STESTERIS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C+)4/6/2026MSAMSA Safety Incorporporated Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C+)3/31/2026MSAMSA Safety Incorporporated Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$200.00 ➝ $180.003/30/2026MSAMSA Safety Incorporporated Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$205.00 ➝ $195.00(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMSAMSA Safety Incorporporated$1.87B3.48$10.04 per share16.85$35.02 per share4.83SNNSmith & Nephew SNATS$6.16B2.15$3.45 per share8.99$12.45 per share2.49STESTERIS$5.94B3.56$13.74 per share15.68$73.39 per share2.94WILYYDemant A/S$3.48B2.20$0.88 per share20.54$3.51 per share5.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMSAMSA Safety Incorporporated$278.92M$7.4022.8517.47N/A15.16%24.54%12.64%8/3/2026 (Estimated)SNNSmith & Nephew SNATS$625MN/AN/A12.341.01N/AN/AN/A8/4/2026 (Estimated)STESTERIS$782.30M$7.9327.1817.90N/A13.18%14.15%9.52%8/5/2026 (Estimated)WILYYDemant A/S$233.91MN/AN/AN/AN/AN/AN/AN/A5/27/2026 (Estimated)Latest STE, SNN, WILYY, and MSA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q4 2026STESTERIS$2.86$2.83-$0.03$2.24$1.59 billion$1.59 billion5/4/2026Q1 2026MSAMSA Safety Incorporporated$1.85$1.99+$0.14$1.83$451.28 million$463.63 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMSAMSA Safety Incorporporated$2.161.28%+4.19%29.19%56 YearsSNNSmith & Nephew SNATS$0.933.00%N/AN/AN/ASTESTERIS$2.521.17%+8.99%31.78%20 YearsWILYYDemant A/SN/AN/AN/AN/AN/ALatest STE, SNN, WILYY, and MSA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2026STESTERISquarterly$0.631.18%6/8/20266/8/20266/26/20265/4/2026MSAMSA Safety Incorporporatedquarterly$0.541.26%5/15/20265/15/20266/10/20263/5/2026SNNSmith & Nephew SNATS$0.48203.04%3/27/20263/27/20265/27/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMSAMSA Safety Incorporporated0.453.171.92SNNSmith & Nephew SNATS0.602.571.25STESTERIS0.252.091.54WILYYDemant A/S1.651.361.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMSAMSA Safety Incorporporated92.51%SNNSmith & Nephew SNATS25.64%STESTERIS94.69%WILYYDemant A/SN/AInsider OwnershipCompanyInsider OwnershipMSAMSA Safety Incorporporated0.70%SNNSmith & Nephew SNATS1.00%STESTERIS1.07%WILYYDemant A/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMSAMSA Safety Incorporporated5,30038.60 million38.33 millionOptionableSNNSmith & Nephew SNATS16,988426.99 million422.72 millionOptionableSTESTERIS17,78798.07 million97.03 millionOptionableWILYYDemant A/S26,704423.51 millionN/ANot OptionableSTE, SNN, WILYY, and MSA HeadlinesRecent News About These CompaniesReviewing Demant A/S (OTCMKTS:WILYY) & Maravai LifeSciences (NASDAQ:MRVI)2 hours ago | americanbankingnews.comDemant shares surge 15% after Oticon Zeal drives Q1 growthMay 7, 2026 | za.investing.comDemant A/S (OTCMKTS:WILYY) Sees Unusually-High Trading Volume - Here's WhyMay 6, 2026 | marketbeat.comDemant A/S: Expansion of Demant's Executive Leadership TeamMay 6, 2026 | finanznachrichten.deDemant A/S (OTCMKTS:WILYY) Shares Gap Down - Should You Sell?April 27, 2026 | marketbeat.comDemant A/S Unsponsored ADR (OTCMKTS:WILYY) Sees Significant Decrease in Short InterestApril 25, 2026 | marketbeat.comJefferies flips on hearing aid giants, upgrades Demant, cuts SonovaMarch 18, 2026 | investing.com3 European Stocks Estimated To Be Trading At Over 49.3% Below Intrinsic ValueFebruary 18, 2026 | finance.yahoo.comDemant tops Q4 forecasts on Diagnostics recovery, but shares tumble on outlookFebruary 4, 2026 | investing.comDemant A/S (WILYY) Q4 2025 Earnings Call TranscriptFebruary 3, 2026 | seekingalpha.comDemant price target lowered to DKK 288 from DKK 291 at JPMorganDecember 16, 2025 | msn.comDemant downgraded to equal weight from overweight at Morgan StanleyDecember 15, 2025 | msn.com'Words that carry weight, carry mana': Demant talks World Cup disappointment and BearsNovember 27, 2025 | rugbypass.comR'Breath of fresh air' to play in PWR - DemantNovember 27, 2025 | msn.comDemant A/S: Investor news - Demant obtains regulatory approval for the acquisition of KINDNovember 19, 2025 | finanznachrichten.deDemant initiated with a Sector Perform at RBC CapitalNovember 18, 2025 | msn.comBlack Ferns star Ruahei Demant heading to BritainNovember 18, 2025 | msn.comRuahei Demant Heads to Bristol Before 2026 ReturnNovember 18, 2025 | allblacks.comABristol Bears confirm signing of ‘genuinely world class’ Ruahei DemantNovember 18, 2025 | rugbypass.comRBlack Ferns star Ruahei Demant to join Bristol BearsNovember 18, 2025 | bristol247.comBBlack Fern Demant to join Bristol on short-term dealNovember 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesIonQ Just Posted a Breakout Quarter—But 1 Problem RemainsBy Nathan Reiff | May 7, 2026STMicronelectronics Sends Industrial Chips Into OverdriveBy Thomas Hughes | April 24, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026Years in the Making, AMD’s Upside Movement Has Just BegunBy Thomas Hughes | May 6, 2026How Williams Companies Is Cashing in on the AI Power BoomBy Chris Markoch | May 6, 2026STE, SNN, WILYY, and MSA Company DescriptionsMSA Safety Incorporporated NYSE:MSA$169.12 +4.01 (+2.43%) Closing price 05/20/2026 03:59 PM EasternExtended Trading$168.96 -0.16 (-0.09%) As of 06:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MSA Safety Incorporated develops, manufactures, and supplies safety products and technology solutions that protect people and facility infrastructures in the fire service, energy, utility, construction, and industrial manufacturing applications, as well as heating, ventilation, air conditioning, and refrigeration industries worldwide. The company's core product offerings include fixed gas and flame detection systems, such as gas detection monitoring systems, and flame detectors and open-path infrared gas detectors; breathing apparatus products, including self-contained breathing apparatus; hand-held portable gas detection instruments to detect the presence or absence of various gases in the air; industrial head protection products; firefighter helmets and protective apparel; and fall protection equipment, such as confined space equipment, harnesses, lanyards, and self-retracting lifelines, as well as engineered systems. In addition, the company offers air-purifying respirators, eye and face protection products, ballistic helmets, and gas masks. It serves distributors and end-users through indirect and direct sales channels. The company offers its products under the V-Gard, Cairns, and Gallet brand names. MSA Safety Incorporated was founded in 1914 and is based in Cranberry Township, Pennsylvania.Smith & Nephew SNATS NYSE:SNN$30.98 +0.14 (+0.44%) Closing price 05/20/2026 03:58 PM EasternExtended Trading$31.01 +0.03 (+0.11%) As of 05:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.STERIS NYSE:STE$215.51 +1.09 (+0.51%) Closing price 05/20/2026 03:59 PM EasternExtended Trading$215.97 +0.46 (+0.21%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.Demant A/S OTCMKTS:WILYY$18.05 0.00 (0.00%) As of 05/19/2026Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
